POM TO P SWITCH

Treating postmenopausal VA symptoms

Learning and support for the pharmacy team

Vaginal atrophy (VA) is a chronic, progressive condition that affects around 1 in 2 postmenopausal women.1,2
The following resources will help you and your team to support women seeking relief from uncomfortable symptoms and educate you about local vaginal oestrogen, which is now available OTC.

Core training

 

Together with the Pharmacy Guide for the Supply of Gina (scroll to Downloads section), these modules comprise the full training programme on VA and Gina.

 

Update your knowledge on this common condition, who it affects and its impact on quality of life

10-minute module

Learn about how Gina works and who can use it

10-minute module

Understand the path to purchase in the pharmacy and the tools available to support supply decisions

10-minute module

Recognise the contraindications and conditions that need GP referral when considering recommending Gina

10-minute module

 

The following videos build on key information within the modules to offer bitesized learning points.

 

Additional videos

 

Build on your knowledge with real-life case studies, and develop your consultation skills further.

 

How VA affected real women

Hear how vaginal atrophy affected Kyriacou, Sheila, Jackie and Camille

3-minute video

Discussing Gina with your patients

A short video on the steps to follow when offering Gina

4-minute video

Downloadable materials

 

Important resources for the whole pharmacy team.

 

Pharmacy Guide for the Supply of Gina

An important comprehensive resource that supports the reclassification to P legal status, to help ensure appropriate supply

Download

Pharmacy Checklist

An optional checklist to support you during consultations with women requesting Gina

Download

Pharmacy Team Training Guide

A downloadable training booklet for the pharmacy team to accompany the core e-learning modules

Download

 

 

References

1. Nappi RE, Palacios S, Particco M, et al. The REVIVE (Real Women’s Views of Treatment Options for Menopausal Vaginal Changes) survey in Europe: Country-specific comparisons of postmenopausal women’s perceptions, experiences and needs. Maturitas 2016;91:81–90.

2. Panay N, Maamari R. Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets. Menopause Int 2012;18(1):15–19.

Further information about this product, including essential supply information, adverse reactions, precautions, contraindications, and method of use can be found here.

UK22GIN00049
August 2022